GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Cash Ratio

WPD Pharmaceuticals (XCNQ:WBIO) Cash Ratio : 0.00 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. WPD Pharmaceuticals's Cash Ratio for the quarter that ended in Jun. 2024 was 0.00.

WPD Pharmaceuticals has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for WPD Pharmaceuticals's Cash Ratio or its related term are showing as below:

During the past 13 years, WPD Pharmaceuticals's highest Cash Ratio was 42.85. The lowest was 0.02. And the median was 0.26.

XCNQ:WBIO's Cash Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.665
* Ranked among companies with meaningful Cash Ratio only.

WPD Pharmaceuticals Cash Ratio Historical Data

The historical data trend for WPD Pharmaceuticals's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Cash Ratio Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.23 0.27 0.79 0.04 0.14

WPD Pharmaceuticals Quarterly Data
Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.24 0.14 0.02 -

Competitive Comparison of WPD Pharmaceuticals's Cash Ratio

For the Biotechnology subindustry, WPD Pharmaceuticals's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WPD Pharmaceuticals's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's Cash Ratio distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's Cash Ratio falls into.



WPD Pharmaceuticals Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

WPD Pharmaceuticals's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.086/0.598
=0.14

WPD Pharmaceuticals's Cash Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash Ratio (Q: Jun. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.003/0.608
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WPD Pharmaceuticals  (XCNQ:WBIO) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


WPD Pharmaceuticals Cash Ratio Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WPD Pharmaceuticals Business Description

Traded in Other Exchanges
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.
Executives
Constantine Carmichel Director

WPD Pharmaceuticals Headlines

No Headlines